Rate of change – The speed at which weight loss and blood sugar changes occur might influence the likelihood of developing vision problems, suggesting that a more gradual approach could be safer.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Medical research reveals rare but serious vision issues in some patients using weight loss medications, prompting experts to share guidance for current users.

LOUISVILLE, Ky. (WKRC) - Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo regular eye examinations due to a potential risk of vision loss.

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

Vision loss may increase or change over a few weeks but should stop progressing after two months, according to the American Academy of Ophthalmology, an association of eye physicians and surgeons.

A small number of patients taking GLP-1 weight loss medications have experienced loss of vision, but researchers say they have not established a direct link to the drugs.

A study links Ozempic and semaglutide with vision loss. Here's what doctors want you need to know about weight loss drugs, type 2 diabetes, and eyesight.

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Scientists remain puzzled as to why some people taking popular weight loss and diabetes medications like Ozempic and Wegovy are losing their vision suddenly, highlighting that there's still so ...